Clinical trials
Not yet recruiting Observational Leukemia, Myeloid, Acute trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 6 |
| 2026 | 12 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Not yet recruiting | 21 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assiut University | 5 |
| Assistance Publique - Hôpitaux de Paris | 2 |
| ARCE Therapeutics, Inc. | 1 |
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 1 |
| Hospices Civils de Lyon | 1 |
| IRCCS San Raffaele | 1 |
| Institute of Hematology & Blood Diseases Hospital, China | 1 |
| Miltenyi Biomedicine GmbH | 1 |
| Nanfang Hospital, Southern Medical University | 1 |
| Nantes University Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Myeloid, Acute | 21 |
| Leukemia | 3 |
| Myelodysplastic Syndromes | 3 |
| Anemia, Refractory, with Excess of Blasts | 2 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 |
| Hematologic Neoplasms | 1 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 |
| Lymphoma | 1 |
| Neoplasm, Residual | 1 |
| Recurrence | 1 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.